1: Kato M, Abe H, Itahashi M, Kikuchihara Y, Kimura M, Mizukami S, Yoshida T,
Shibutani M. Maternal exposure to hexachlorophene targets intermediate-stage
progenitor cells in the hippocampal neurogenesis involving myelin vacuolation of
cholinergic and glutamatergic inputs in mice. J Appl Toxicol. 2016
Feb;36(2):211-22. doi: 10.1002/jat.3162. Epub 2015 May 5. PubMed PMID: 25943520.
2: Narayan M, Peralta DA, Gibson C, Zitnyar A, Jinwal UK. An optimized InCell
Western screening technique identifies hexachlorophene as a novel potent TDP43
targeting drug. J Biotechnol. 2015 Aug 10;207:34-8. doi:
10.1016/j.jbiotec.2015.04.012. Epub 2015 May 16. PubMed PMID: 25987361.
3: Itahashi M, Abe H, Tanaka T, Mizukami S, Kimura M, Yoshida T, Shibutani M.
Maternal exposure to hexachlorophene targets intermediate-stage progenitor cells
of the hippocampal neurogenesis in rat offspring via dysfunction of cholinergic
inputs by myelin vacuolation. Toxicology. 2015 Feb 3;328:123-34. doi:
10.1016/j.tox.2014.12.009. Epub 2014 Dec 11. PubMed PMID: 25497112.
4: Erdos Z, Pearson K, Goedken M, Menzel K, Sistare FD, Glaab WE, Saldutti LP.
Inhibin B response to testicular toxicants hexachlorophene, ethane dimethane
sulfonate, di-(n-butyl)-phthalate, nitrofurazone, DL-ethionine, 17-alpha
ethinylestradiol, 2,5-hexanedione, or carbendazim following short-term dosing in
male rats. Birth Defects Res B Dev Reprod Toxicol. 2013 Feb;98(1):41-53. doi:
10.1002/bdrb.21035. Epub 2013 Jan 24. PubMed PMID: 23348767.
5: Kanno T, Sasaki S, Yamada N, Kawasako K, Tsuchitani M. Hexachlorophene and
cuprizone induce the spongy change of the developing rat brain by different
mechanisms: the role of 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase). J
Vet Med Sci. 2012 Jul;74(7):837-43. Epub 2012 Feb 8. PubMed PMID: 22313968.
6: Miller LG, Tan J, Eells SJ, Benitez E, Radner AB. Prospective investigation of
nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for
prevention of recurrent community-associated methicillin-resistant Staphylococcus
aureus infections. Antimicrob Agents Chemother. 2012 Feb;56(2):1084-6. doi:
10.1128/AAC.01608-10. Epub 2011 Nov 14. PubMed PMID: 22083485; PubMed Central
PMCID: PMC3264243.
7: Zheng Y, Zhu X, Zhou P, Lan X, Xu H, Li M, Gao Z. Hexachlorophene is a potent
KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutants. PLoS One.
2012;7(12):e51820. doi: 10.1371/journal.pone.0051820. Epub 2012 Dec 12. PubMed
PMID: 23251633; PubMed Central PMCID: PMC3520906.
8: Min HJ, Cho IR, Srisuttee R, Park EH, Cho DH, Ahn JH, Lee IS, Johnston RN, Oh
S, Chung YH. Hexachlorophene suppresses beta-catenin expression by up-regulation
of Siah-1 in EBV-infected B lymphoma cells. Cancer Lett. 2009 Apr
18;276(2):136-42. doi: 10.1016/j.canlet.2008.10.041. Epub 2008 Dec 16. PubMed
PMID: 19091460.
9: Park S, Gwak J, Cho M, Song T, Won J, Kim DE, Shin JG, Oh S. Hexachlorophene
inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin
degradation. Mol Pharmacol. 2006 Sep;70(3):960-6. Epub 2006 May 30. PubMed PMID:
16735606.
10: Marcinkeviciene J, Jiang W, Kopcho LM, Locke G, Luo Y, Copeland RA. Enoyl-ACP
reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and
inhibition by triclosan and hexachlorophene. Arch Biochem Biophys. 2001 Jun
1;390(1):101-8. Erratum in: Arch Biochem Biophys 2001 Dec 15;396(2):249. PubMed
PMID: 11368521.
11: Kinoshita Y, Matsumura H, Igisu H, Yokota A. Hexachlorophene-induced brain
edema in rat observed by proton magnetic resonance. Brain Res. 2000 Aug
4;873(1):127-30. PubMed PMID: 10915818.
12: Häntzschel A, Andreas K. Efficacy of glutamate receptor antagonists in the
management of functional disorders in cytotoxic brain oedema induced by
hexachlorophene. Pharmacol Toxicol. 1998 Feb;82(2):80-8. PubMed PMID: 9498236.
13: Matsumura H, Matsuoka M, Igisu H, Ikeda M. Cooperative inhibition of
acetylcholinesterase activities by hexachlorophene in human erythrocytes. Arch
Toxicol. 1997;71(3):151-6. PubMed PMID: 9049051.
14: Flanagan RJ, Ruprah M, Strutt AV, Malarkey P, Cockburn A. Effect of urinary
alkalinisation and acidification on the tissue distribution of hexachlorophene in
rats. Hum Exp Toxicol. 1995 Oct;14(10):795-800. PubMed PMID: 8562119.
15: Reasor MJ, Montgomery MR. Hexachlorophene exposure in a young patient with
soft tissue sarcoma. Br J Ind Med. 1993 Jul;50(7):670. PubMed PMID: 8343430;
PubMed Central PMCID: PMC1035506.
16: Andreas K, Blaschke M, Bergsträsser E, Fischer HD, Schmidt J. Neurochemical
characterization of hexachlorophene induced brain oedema. Arch Toxicol Suppl.
1991;14:30-2. PubMed PMID: 1839603.
17: Poppenga RH, Trapp AL, Braselton WE, Louden CG, Gumbs JM, Dalley JB.
Hexachlorophene toxicosis in a litter of Doberman pinschers. J Vet Diagn Invest.
1990 Apr;2(2):129-31. PubMed PMID: 2094434.
18: Kung MP, Nickerson PA, Sansone FM, Olson JR, Kostyniak PJ, Adolf MA, Lein PJ,
Roth JA. Effect of short-term exposure to hexachlorophene on rat brain cell
specific marker enzymes. Fundam Appl Toxicol. 1988 Oct;11(3):519-27. PubMed PMID:
2906023.
19: Rajendra W, Prasad GV, Indira K. Deviations in hepatic amino acid profiles of
mouse following repeated hexachlorophene administration. J Environ Sci Health B.
1988 Aug;23(4):409-26. PubMed PMID: 3192908.
20: Vorherr H, Vorherr UF, Moss JC. Comparative effectiveness of chlorhexidine,
povidone-iodine, and hexachlorophene on the bacteria of the perineum and groin of
pregnant women. Am J Infect Control. 1988 Aug;16(4):178-81. PubMed PMID: 3189944.
